Related Experiment Video
Updated: Jan 20, 2026

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
Published on: May 19, 2010
Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination
Leslie Kirby1, Jing Jin1, Jaime Gonzalez Cardona1
1Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Abstract:
Oligodendrocyte precursor cells (OPCs) are abundant in the adult central nervous system, and have the capacity to regenerate oligodendrocytes and myelin. However, in inflammatory diseases such as multiple sclerosis (MS) remyelination is often incomplete. To investigate how neuroinflammation influences OPCs, we perform in vivo fate-tracing in an inflammatory demyelinating mouse model. Here we report that OPC differentiation is inhibited by both effector T cells and IFNγ overexpression by astrocytes. IFNγ also reduces the absolute number of OPCs and alters remaining OPCs by inducing the immunoproteasome and MHC class I. In vitro, OPCs exposed to IFNγ cross-present antigen to cytotoxic CD8 T cells, resulting in OPC death. In human demyelinated MS brain lesions, but not normal appearing white matter, oligodendroglia exhibit enhanced expression of the immunoproteasome subunit PSMB8. Therefore, OPCs may be co-opted by the immune system in MS to perpetuate the autoimmune response, suggesting that inhibiting immune activation of OPCs may facilitate remyelination.
Related Concept Videos
08:11Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
04:27An In Vitro Transduction-Induced Myelination Assay for Oligodendrocyte Precursor Cells
04:39Isolating and Culturing Oligodendrocyte Precursor Cells from Mouse Pup Brain Cortex
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:36High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures
03:50An Ex Vivo Technique to Induce Neuronal Death via Oligodendrocyte-Specific CD8+ T Cells

